Charleah Vega, a 43-year-old Boston resident, struggled with obesity after childbirth, reaching 236 pounds
In one multicenter study, GLP-1 medicine use was associated with lower risks of major heart events, blood clots, kidney disease progression, and death compared with DPP-4 inhibitor medicines in patients with lupus and type 2 diabetes
Additionally, many patients give up the treatment, whether because they are buying it privately so cannot afford it, because the side-effects do not suit them or because they are not losing weight any more
Table of Contents Change Your Life Today For Only $249/month Introduction Semaglutide is a medication that many people use to help manage type 2 diabetes and aid in weight loss
While this may limit the generalizability of the studys outcomes to a certain degree, the overall trend remained consistent across all racial and ethnic groups